Issue

Vol. 27 No. 8 (2015): Vol 27 Issue 8

Copyright (c) 2015 AJC

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Synthetic Organo-Selenium Compounds in Medicinal Domain: A Review

https://doi.org/10.14233/ajchem.2015.18834
Showket Ahmad Akhoon
Department of Chemistry, University of Kashmir, Srinagar-190 006, India
Tahira Naqvi
Department of School Education, Jammu & Kashmir Government, Jammu & Kashmir, India
Safiya Nisar
Department of Chemistry, University of Kashmir, Srinagar-190 006, India
Masood Ahmad Rizvi
Department of Chemistry, University of Kashmir, Srinagar-190 006, India

Corresponding Author(s) : Masood Ahmad Rizvi

masood_ku2@yahoo.com

Asian Journal of Chemistry, Vol. 27 No. 8 (2015): Vol 27 Issue 8

Abstract

Organoselenium chemistry has emerged as an outstanding area in recent years due to its essential role in synthesis of a large number of biologically active compounds and important therapeutic products. The design and synthesis of organoselenium compounds with improved biological activity continues to be an active area of research. This minireview discusses the different medicinal applications of a plethora of synthetic organoselenium compounds from last two and a half decade. This mini review is aimed to be handy reference for synthetic chemists in designing and synthesizing novel organoselenium compounds of therapeutic significance.

Keywords

Organo-selenium compounds Medicinal applications Ebselen Glutathione peroxidase Cytoxicity
Ahmad Akhoon, S., Naqvi, T., Nisar, S., & Ahmad Rizvi, M. (2015). Synthetic Organo-Selenium Compounds in Medicinal Domain: A Review. Asian Journal of Chemistry, 27(8), 2745–2752. https://doi.org/10.14233/ajchem.2015.18834
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. K. Schwarz and C.M. Foltz, J. Am. Chem. Soc., 79, 3292 (1957); doi:10.1021/ja01569a087.
  2. D.N. Jones, D. Mundy and R.D. Whitehouse, J. Chem. Soc. Chem. Commun., 86 (1970); doi:10.1039/c29700000086.
  3. T. Posser, M.P. Kaster, S.C. Baraúna, J.B.T. Rocha, A.L.S. Rodrigues and R.B. Leal, Eur. J. Pharmacol., 602, 85 (2009); doi:10.1016/j.ejphar.2008.10.055.
  4. S. Watabe, Y. Makino, K. Ogawa, T. Hiroi, Y. Yamamoto and S.Y. Takahashi, Eur. J. Biochem., 264, 74 (1999); doi:10.1046/j.1432-1327.1999.00578.x.
  5. T. Ogunmoyole, J.B.T. Rocha, A.E. Okoronkwo and I.J. Kade, Chem. Biol. Interact., 182, 106 (2009); doi:10.1016/j.cbi.2009.08.018.
  6. R. Naithani, Mini Rev. Med. Chem., 8, 657 (2008); doi:10.2174/138955708784567368.
  7. L. Shen, K.M. Shin, K.T. Lee and J.H. Jeong, Arch. Pharm. Res., 27, 816 (2004); doi:10.1007/BF02980171.
  8. M. Parnham and E. Graf, Pharmacology of Synthetic Organic Selenium Compounds, In: Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progrès des recherches pharmaceutiques, Birkhäuser Basel, vol. 36, pp. 9-47 (1991).
  9. S.W. May, L. Wang, M.M. Gill-Woznichak, R.F. Browner, A.A. Ogonowski, J.B. Smith and S.H. Pollock, J. Pharmacol. Exp. Ther., 283, 470 (1997).
  10. A. Lescure, D. Gautheret, P. Carbon and A. Krol, J. Biol. Chem., 274, 38147 (1999); doi:10.1074/jbc.274.53.38147.
  11. B.S. Reddy, B. Simi and C.V. Rao, Anticancer Res., 14, 6 (1994).
  12. J. Nayini, K. El-Bayoumy, S. Sugie, L.A. Cohen and B.S. Reddy, Carcinogenesis, 10, 509 (1989); doi:10.1093/carcin/10.3.509.
  13. R.J. Shamberger, Biochemistry of Selenium, Plenum Press: New York (1983).
  14. H.B. Singh and N. Sudha, Polyhedron, 15, 745 (1996); doi:10.1016/0277-5387(95)00249-X.
  15. S. Somasundaram, C.R. Chenthamarakshan, N.R. de Tacconi, Y. Ming and K. Rajeshwar, Chem. Mater., 16, 3846 (2004); doi:10.1021/cm049293b.
  16. J.G. Brennan, T. Siegrist, P.J. Carroll, S.M. Stuczynski, L.E. Brus and M.L. Steigerwald, J. Am. Chem. Soc., 111, 4141 (1989); doi:10.1021/ja00193a079.
  17. K.A. Leonard, J.P. Hall, M.I. Nelen, S.R. Davies, S.O. Gollnick, S. Camacho, A.R. Oseroff, S.L. Gibson, R. Hilf and M.R. Detty, J. Med. Chem., 43, 4488 (2000); doi:10.1021/jm000154p.
  18. J.W. Forstrom, J.J. Zakowski and A.L. Tappel, Biochemistry, 17, 2639 (1978); doi:10.1021/bi00606a028.
  19. S.C. Low, J.W. Harney and M.J. Berry, J. Biol. Chem., 270, 21659 (1995); doi:10.1074/jbc.270.37.21659.
  20. T. Mizutani, K. Kanaya and K. Tanabe, Biofactors, 9, 27 (1999); doi:10.1002/biof.5520090105.
  21. M. Muttenthaler and P.F. Alewood, J. Pept. Sci., 14, 1223 (2008); doi:10.1002/psc.1075.
  22. M.A. Rizvi, S. Guru, T. Naqvi, M. Kumar, N. Kumbhar, S. Akhoon, S. Banday, S.K. Singh, S. Bhushan, G.M. Peerzada and B.A. Shah, Bioorg. Med. Chem. Lett. 24, 3440 (2014); doi:10.1016/j.bmcl.2014.05.075.
  23. M.A. Rizvi, M. Zaki, M. Afzal , M. Mane, M. Kumar, B.A. Shah, S. Srivastav, S. Srikrishna, G.M. Peerzada and S. Tabassum. Eur. J. Med. Chem., 90, 876 (2015); doi:10.1016/j.ejmech.2014.12.014.
  24. K. Takahashi, N. Avissar, J. Whitin and H. Cohen, Arch. Biochem. Biophys., 256, 677 (1987); doi:10.1016/0003-9861(87)90624-2.
  25. T.C. Stadtman, J. Biol. Chem., 266, 16257 (1991).
  26. G. Mugesh and H.B. Singh, Chem. Soc. Rev., 29, 347 (2000); doi:10.1039/a908114c.
  27. A. Muller, E. Cadenas, P. Graf and H. Sies, Biochem. Pharmacol., 33, 3235 (1984); doi:10.1016/0006-2952(84)90083-2.
  28. G. Mugesh, A. Panda, H.B. Singh, N.S. Punekar and R.J. Butcher, J. Am. Chem. Soc., 123, 839 (2001); doi:10.1021/ja994467p.
  29. M. Iwaoka and S. Tomoda, J. Am. Chem. Soc., 116, 2557 (1994); doi:10.1021/ja00085a040.
  30. H. Sies, V.S. Sharov, L.O. Klotz and K. Briviba, J. Biol. Chem., 272, 27812 (1997); doi:10.1074/jbc.272.44.27812.
  31. H. Masumoto and H. Sies, Chem. Res. Toxicol., 9, 1057 (1996); doi:10.1021/tx9600560.
  32. N. Noguchi, Y. Yoshida, H. Kaneda, Y. Yamamoto and E. Niki, Biochem. Pharmacol., 44, 39 (1992); doi:10.1016/0006-2952(92)90035-H.
  33. C. Parashiva Prabhu, P.P. Phadnis, A.P. Wadawale, K. Indira Priyadarsini and V.K. Jain, J. Organomet. Chem., 713, 42 (2012); doi:10.1016/j.jorganchem.2012.04.014.
  34. J.F. Wang, P. Komarov, H. Sies and H. de Groot, Biochem. J., 279, 311 (1991).
  35. R.J. Hatchett, J. Mlochowski, A. Zembowicz and W. Radziszewski, J. Physiol. Pharmacol., 45, 55 (1994).
  36. J. Balzarini, C.K. Lee, D. Schols and E. De Clercq, Biochem. Biophys. Res. Commun., 178, 563 (1991); doi:10.1016/0006-291X(91)90145-W.
  37. P.C. Srivastava and R.K. Robins, J. Med. Chem., 26, 445 (1983); doi:10.1021/jm00357a024.
  38. D.G. Streeter and R.K. Robins, Biochem. Biophys. Res. Commun., 115, 544 (1983); doi:10.1016/S0006-291X(83)80179-X.
  39. H.N. Jayaram, G.S. Ahluwalia, R.L. Dion, G. Gebeyehu, V.E. Marquez, J.A. Kelley, R.K. Robins, D.A. Cooney and D.G. Johns, Biochem. Pharmacol., 32, 2633 (1983); doi:10.1016/0006-2952(83)90038-2.
  40. D.F. Smee, L.L. Hall, J.W. Huggins and R.W. Sidwell, Antivir. Chem. Chemother., 1, 211 (1990).
  41. Y. Tabuchi, N. Sugiyama, T. Horiuchi, M. Furusawa and K. Furuhama, Eur. J. Pharmacol., 272, 195 (1995); doi:10.1016/0014-2999(95)90819-U.
  42. I.A. Cotgreave, S.K. Duddy, G.E.N. Kass, D. Thompson and P. Moldéus, Biochem. Pharmacol., 38, 649 (1989); doi:10.1016/0006-2952(89)90211-6.
  43. P.V. Jacquemin, L.E. Christiaens, M.J. Renson, M.J. Evers and N. Dereu, Tetrahedron Lett., 33, 3863 (1992); doi:10.1016/S0040-4039(00)74805-2.
  44. O.I. Aruoma, The Vascular System, 28, 269 (1997); doi:10.1016/S0306-3623(96)00232-7.
  45. Y. Liu, B. Li, L. Li and H.Y. Zhang, HeIv. Chim. Acta, 85, 9 (2002); doi:10.1002/1522-2675(200201)85:1<9::AID-HLCA9>3.0.CO;2-H.
  46. C.W. Nogueira, E.B. Quinhones, E.A.C. Jung, G. Zeni and J.B.T. Rocha, Inflamm. Res., 52, 56 (2003); doi:10.1007/s000110300001.
  47. R.J. Shamberger and D.V. Frost, Can. Med. Assoc. J., 100, 682 (1969).
  48. K. El-Bayoumy, Cancer Res., 45, 3631 (1985).
  49. B.S. Reddy, S. Sugie, H. Maruyama, K. El-Bayoumy and P. Marra, Cancer Res., 47, 5901 (1987).
  50. P.G. Foiles, Int. J. Oncol., 2, 413 (1993).
  51. E.S. Fiala, M.E. Staretz, G.A. Pandya, K. El-Bayoumy and S.R. Hamilton, Carcinogenesis, 19, 597 (1998); doi:10.1093/carcin/19.4.597.
  52. P.G. Foiles, Int. J. Oncol., 7, 685 (1995).
  53. C.C. Conaway, P. Upadhyaya, C.L. Meschter, C. Kurtzke, L.A. Marcus and K. Et-Bayoumy, Toxicol. Sci., 19, 563 (1992); doi:10.1093/toxsci/19.4.563.
  54. B.S. Reddy, A. Rivenson, N. Kulkarni, P. Upadhyaya and K. El-Bayoumy, Cancer Res., 52, 5635 (1992).
  55. T. Tanaka, H. Kohno, M. Murakami, S. Kagami and K. El-Bayoumy, Cancer Res., 60, 3713 (2000).
  56. T. Tanaka, H. Makita, K. Kawabata, H. Mori and K. El-Bayoumy, Cancer Res., 57, 3644 (1997).
  57. T. Kawamor, Int. J. Oncol., 13, 29 (1998).
  58. M.D. Short, Y. Xie, L. Li, P.B. Cassidy and J.C. Roberts, J. Med. Chem., 46, 3308 (2003); doi:10.1021/jm020496q.
  59. K. El-Bayoumy, Anticancer Res., 16, 2911 (1996).
  60. K.M. Wu, M. Koketsu, Y. Yamada and I. Saiki, Anticancer Res., 19, 5375 (1999).
  61. J. Venhorst, M. Rooseboom, N.P. Vermeulen and J.N. Commandeur, Xenobiotica, 33, 57 (2003); doi:10.1080/0049825021000022357.
  62. J. Lu, C. Jiang, M. Kaeck, H. Ganther, S. Vadhanavikit, I.P. Clement and H. Thompson, Biochem. Pharmacol., 50, 213 (1995); doi:10.1016/0006-2952(95)00119-K.
  63. C. Shi, L. Yu, F. Yang, J. Yan and H. Zeng, Biochem. Biophys. Res. Commun., 309, 578 (2003); doi:10.1016/j.bbrc.2003.08.032.
  64. H. Ito, K. Shimura, J. Sakakibara and T. Ueda, Anticancer Res., 10, 891 (1990).
  65. A. Wendel and G. Tiegs, Biochem. Pharmacol., 35, 2115 (1986); doi:10.1016/0006-2952(86)90578-2.
  66. E.N. Maciel, R.C. Bolzan, A.L. Braga and J.B.T. Rocha, J. Biochem. Mol. Toxicol., 14, 310 (2000); doi:10.1002/1099-0461(2000)14:6<310::AID-JBT3>3.0.CO;2-D.
  67. D.A. Dawson, H. Masayasu, D.I. Graham and I.M. Macrae, Neurosci. Lett., 185, 65 (1995); doi:10.1016/0304-3940(94)11226-9.
  68. S. Knollema, J.W. Elting, R.M. Dijkhuizen, K. Nicolay, J. Korf and G.J. Ter Horst, Neurosci. Res. Commun., 19, 47 (1996); doi:10.1002/(SICI)1520-6769(199607)19:1<47::AID-NRC162>3.0.CO;2-8.
  69. G.A. Herin, S. Du and E. Aizenman, J. Neurochem., 78, 1307 (2001); doi:10.1046/j.1471-4159.2001.00517.x.
  70. G. Ghisleni, L.O. Porciancula, H. Cimarosti, T. Batista, J. Rocha, C.G. Salbego and D.O. Souza, Brain Res., 986, 196 (2003); doi:10.1016/S0006-8993(03)03193-7.
  71. R.M. Rosa, D.G. Flores, H.R. Appelt, A.L. Braga, J.A. Henriques and R. Roesler, Neurosci. Lett., 341, 217 (2003); doi:10.1016/S0304-3940(03)00187-3.
  72. C.K. Chu, L. Ma, S. Olgen, C. Pierra, J. Du, G. Gumina, E. Gullen, Y.C. Cheng and R.F. Schinazi, J. Med. Chem., 43, 3906 (2000); doi:10.1021/jm990113x.
  73. J. Mlochowski and K. Kloc, ARKIVOC, 14 (2006); doi:10.3998/ark.5550190.0008.603.
  74. M.J. Parnham and E. Graf, Prog. Drug Res., 36, 9 (1991).
  75. H. Wójtowicz, K. Kloc, I. Maliszewska, J. Młochowski, M. Piętka and E. Piasecki, IL Farmaco, 59, 863 (2004); doi:10.1016/j.farmac.2004.07.003.
  76. A.D. Inglot, J. Zieliñska-Jenczylik, E. Piasecki, L. Syper and J. Mlochowski, J. Experientia, 46, 308 (1990); doi:10.1007/BF01951774.
  77. M. Cembrzyńska-Nowak, E. Szklarz and A.D. Inglot, J. Interferon Cytokine Res., 17, 609 (1997); doi:10.1089/jir.1997.17.609.
  78. H.H. Herman, P.A. Husain, J.E. Colbert, M.M. Schweri, S.H. Pollock, L.C. Fowler and S.W. May, J. Med. Chem., 34, 1082 (1991); doi:10.1021/jm00107a031.
  79. D.W. Combs, M.S. Rampulla, J.P. Demers, R. Falotico and J.B. Moore, J. Med. Chem., 35, 172 (1992); doi:10.1021/jm00079a023.
  80. M.C. Forest, P. Lahouratate, M. Martin, G. Nadler, M.J. Quiniou and R.G. Zimmermann, J. Med. Chem., 35, 163 (1992); doi:10.1021/jm00079a022.
Read More
Author biographies is not available.
Download
PDF
Statistic
Read Counter : 0 Download : 0